Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3875785rdf:typepubmed:Citationlld:pubmed
pubmed-article:3875785lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:3875785lifeskim:mentionsumls-concept:C0301872lld:lifeskim
pubmed-article:3875785lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:3875785lifeskim:mentionsumls-concept:C0205171lld:lifeskim
pubmed-article:3875785lifeskim:mentionsumls-concept:C2348628lld:lifeskim
pubmed-article:3875785pubmed:issue4lld:pubmed
pubmed-article:3875785pubmed:dateCreated1985-10-18lld:pubmed
pubmed-article:3875785pubmed:abstractTextBALB/c mice were immunized with monoclonal BALB/c antibodies IDA10, IDA16 and IDA17 raised against the BALB/c ABPC48 myeloma protein. Several procedures of immunization--copolymers with lipopolysaccharide or keyhole limpet hemocyanin, simultaneous or sequential injections of different IDAs--were performed in an attempt to orient the immune response towards the production of ABPC48-like idiotypes. We used a binding assay which identifies two idiotopes on the same molecule to measure the population of antibodies induced in these responses. The expression of ABPC48 cross-reactive idiotypes in immune sera was analyzed. The results show that, with all immunization protocols, immune responses to different monoclonal antiidiotypic antibodies are mostly independent of each other: the coexpression of ABPC48 idiotopes, either private or recurrent on the induced antibodies, is rarely found; it makes it difficult to discriminate by a serological approach between cross-reactive idiotypes and anti-antiidiotypic antibodies. We discuss the interest of combining molecular and serological approaches to identify these two populations of antibodies.lld:pubmed
pubmed-article:3875785pubmed:languageenglld:pubmed
pubmed-article:3875785pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3875785pubmed:citationSubsetIMlld:pubmed
pubmed-article:3875785pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3875785pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3875785pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3875785pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3875785pubmed:statusMEDLINElld:pubmed
pubmed-article:3875785pubmed:monthAprlld:pubmed
pubmed-article:3875785pubmed:issn0161-5890lld:pubmed
pubmed-article:3875785pubmed:authorpubmed-author:ButtinGGlld:pubmed
pubmed-article:3875785pubmed:authorpubmed-author:SanchezPPlld:pubmed
pubmed-article:3875785pubmed:authorpubmed-author:LegrainPPlld:pubmed
pubmed-article:3875785pubmed:issnTypePrintlld:pubmed
pubmed-article:3875785pubmed:volume22lld:pubmed
pubmed-article:3875785pubmed:ownerNLMlld:pubmed
pubmed-article:3875785pubmed:authorsCompleteYlld:pubmed
pubmed-article:3875785pubmed:pagination445-53lld:pubmed
pubmed-article:3875785pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3875785pubmed:meshHeadingpubmed-meshheading:3875785-...lld:pubmed
pubmed-article:3875785pubmed:meshHeadingpubmed-meshheading:3875785-...lld:pubmed
pubmed-article:3875785pubmed:meshHeadingpubmed-meshheading:3875785-...lld:pubmed
pubmed-article:3875785pubmed:meshHeadingpubmed-meshheading:3875785-...lld:pubmed
pubmed-article:3875785pubmed:meshHeadingpubmed-meshheading:3875785-...lld:pubmed
pubmed-article:3875785pubmed:meshHeadingpubmed-meshheading:3875785-...lld:pubmed
pubmed-article:3875785pubmed:meshHeadingpubmed-meshheading:3875785-...lld:pubmed
pubmed-article:3875785pubmed:meshHeadingpubmed-meshheading:3875785-...lld:pubmed
pubmed-article:3875785pubmed:meshHeadingpubmed-meshheading:3875785-...lld:pubmed
pubmed-article:3875785pubmed:meshHeadingpubmed-meshheading:3875785-...lld:pubmed
pubmed-article:3875785pubmed:meshHeadingpubmed-meshheading:3875785-...lld:pubmed
pubmed-article:3875785pubmed:meshHeadingpubmed-meshheading:3875785-...lld:pubmed
pubmed-article:3875785pubmed:year1985lld:pubmed
pubmed-article:3875785pubmed:articleTitleImmune response induced by a single or several syngeneic monoclonal antiABPC48 antiidiotypic antibodies: no predominant coexpression of ABPC48 idiotopes.lld:pubmed
pubmed-article:3875785pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3875785pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed